首页> 外文期刊>Bone marrow transplantation >Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.
【24h】

Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface.

机译:预防造血细胞移植受者的传染性并发症的指南:全球视角。 前言。

获取原文
获取原文并翻译 | 示例
       

摘要

This report, cosponsored by Center for International Blood & Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Group for Blood and Marrow Transplantation (EBMT), American Society for Blood and Marrow Transplantation (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Association of Medical Microbiology and Infectious Disease (AMMI), Centers for Disease Control (CDC) and the Health Resources and Services Administration, represents an update of the guidelines published in 2000 for preventing infections among hematopoietic cell transplant (HCT) recipients. An international group of experts in infectious diseases, hematopoietic cell transplantation and public health worked together to compile this document with four goals in mind: (1) to summarize the current available data in the field; (2) to provide evidence-based recommendations regarding the prevention of infectious complications among HCT patients; (3) to serve as a reference for health-care providers worldwide who care for HCT recipients; and (4) to serve as a reference for HCT recipients and their nonmedical caregivers. In updating these guidelines, the committee sought to summarize the currently available data and present them as concisely as possible in an evidence-based manner.
机译:本报告,由国际血和骨髓移植研究中心(Cibmtr),国家骨髓捐助计划(NMDP),欧洲血液和骨髓移植(EBMT),美国血液和骨髓移植(ASBMT),加拿大血液和骨髓移植组(CBMTG),美国传染病学会(IDSA),美国医疗保健社会(SHEA),医学微生物学和传染病协会(AMMI),疾病控制中心(CDC)和健康资源和服务管理,代表预防造血细胞移植(HCT)受者的感染的2000年发表的指南的更新。国际传染病的国际专家组,造血细胞移植和公共卫生合作,共同撰写了四个目标:(1)总结该领域的当前可用数据; (2)为预防HCT患者的传染性并发​​症提供基于证据的建议; (3)作为全球卫生保健提供者的参考,该提供者关心HCT接受者; (4)作为HCT接受者及其非医疗照顾者的参考。在更新这些指导方针时,委员会试图总结当前可用的数据,并以循证方式尽可能简明地展示它们。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号